Use of imidazo[2,1-b)]-1,3,4-thiadiazole-2-sulfona mide compounds to treat neuropathic pain

Details for Australian Patent Application No. 2007240082 (hide)

Owner Aegera Therapeutics Inc.

Inventors Durkin, Jon; Hewitt, Kimberley; Winocour, Peter

Agent Spruson & Ferguson

Pub. Number AU-A-2007240082

PCT Pub. Number WO2007/118318

Priority 60/799,480 11.05.06 US; 60/791,473 13.04.06 US

Filing date 13 April 2007

Wipo publication date 25 October 2007

International Classifications

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/4439 (2006.01)

A61K 31/454 (2006.01)

A61K 31/497 (2006.01)

A61K 31/5377 (2006.01)

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

Event Publications

13 November 2008 PCT application entered the National Phase

  PCT publication WO2007/118318 Priority application(s): WO2007/118318

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007240092-Methods of preparing hydrocarbon, water and organophilic clay emulsions and compositions thereof

2007240079-Enhancing software application features and content objects